Indian markets experienced heavy selling pressure due to modest GDP and corporate earnings estimates. Only four smallcap stocks posted double digit weekly returns, while 176 fell significantly. Foreign investors sold nearly $2 billion, and rising US bond yields impacted sentiment. Key earnings and macro data, including India’s CPI release, will guide market direction.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.
May 25, 2026